Advertisement
Screener

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) EBITDA

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income $19.29M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income $11.47M; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA (m); Operating income $11.76M; Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA (m); Operating income -$512.67M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2008-12-31 to 2020-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)$19.29M(m)$418.76M(m)$12.31M*$22.80M*$199.02M(m)$172.44M$262.00K
2026-03-31Reported(m)$11.47M(m)$391.92M(m)$14.85M$9.80M$174.94M(m)$178.24M$2.21M
2025-09-30Reported(m)$11.76M(m)$402.06M(m)$15.16M*$40.91M*$195.07M(m)$169.05M-$1.42M
2025-06-30Reported(m)-$512.67M(m)$415.61M(m)$20.15M*$8.92M*$206.27M(m)$179.89M-$46.88M
2025-03-31Reported(m)-$15.50M(m)$382.65M(m)$28.92M-$11.26M$188.22M(m)$181.50M-$4.74M
2024-09-30Reported(m)-$8.15M(m)$380.83M(m)$29.65M*$22.48M*$180.60M(m)$177.19M-$9.67M
2024-06-30Reported(m)-$3.03M(m)$418.18M(m)$29.71M*$40.40M*$192.26M(m)$195.47M-$2.78M
2024-03-31Reported(m)$3.96M(m)$368.87M(m)$15.46M$15.76M$162.04M(m)$165.80M-$1.95M
2023-09-30Reported(m)$26.59M(m)$382.42M(m)$13.08M*$26.77M*$164.08M(m)$161.95M-$888.00K
2023-06-30Reported(m)$12.50M(m)$381.27M(m)$15.55M*$28.28M*$174.24M(m)$164.91M-$360.00K
2023-03-31Reported(m)$36.38M(m)$380.85M(m)$13.70M$26.16M$147.97M(m)$166.66M$5.55M
2022-09-30Reported(m)$65.05M(m)$385.19M(m)$9.15M*$68.31M*$148.44M(m)$143.82M$8.88M
2022-06-30Reported(m)$59.87M(m)$397.81M(m)$9.41M*$66.48M*$148.40M(m)$160.65M$6.79M
2022-03-31Reported(m)$46.16M(m)$376.64M(m)$9.32M$44.34M$142.57M(m)$159.93M$6.41M
2021-09-30Reported(m)$56.44M(m)$386.86M(m)$7.29M*$82.78M*$144.47M(m)$156.01M$7.56M
2021-06-30Reported(m)$51.85M(m)$389.99M(m)$6.63M*$91.29M*$151.27M(m)$162.55M$9.76M
2021-03-31Reported(m)$30.71M(m)$360.07M(m)$6.67M$69.08M$145.82M(m)$156.63M$21.88M
2020-09-30Reported(m)$57.54M(m)$370.23M(m)$6.73M*$69.64M*$134.81M(m)$150.08M$9.17M
2020-06-30Reported$43.76M*$14.08M$29.68M*$258.67M16.92%*$7.22M*$33.12M*$105.48M$14.93M$116.11M$2.02M
2020-03-31Reported$56.25M(m)(m)(m)15.88%$16.52M$20.81M$133.48M$20.82M$165.95M$2.26M
2019-12-31Reported$63.96M(m)(m)(m)16.19%(m)(m)(m)(m)(m)(m)
2019-09-30Reported$7.01M*-$20.59M$27.60M*$379.10M1.85%*$13.59M*$64.24M*$142.64M$19.00M$173.10M$101.00K
2019-06-30Reported$72.85M*$45.96M$26.89M*$383.64M18.99%*$17.66M*$48.52M*$143.67M$17.63M$165.38M$6.65M
2019-03-31Reported$59.4M(m)(m)(m)16.51%$16.09M$29.48M$128.91M$18.32M$174.87M-$7.93M
2018-12-31Reported$61.79M(m)(m)(m)16.12%(m)(m)(m)(m)(m)(m)
2018-09-30Reported$52.73M*$23.68M$29.05M*$365.85M14.41%*$16.67M*$79.25M*$143.25M$20.31M$173.35M-$2.27M
2018-06-30Reported$54.54M*$27.63M$26.91M*$366.19M14.89%*$20.00M*$36.21M*$137.56M$19.11M$176.60M$1.35M
2018-03-31Reported$52.68M(m)(m)(m)14.75%$15.39M$41.53M$144.22M$18.32M$163.57M-$1.86M
2017-12-31Reported$33.88M(m)(m)(m)9.19%(m)(m)(m)(m)(m)(m)
2017-09-30Reported$31.61M*$10.64M$20.97M*$278.83M11.34%*$7.80M*$45.24M*$101.76M$15.03M$145.94M$76.00K
2017-06-30Reported$38.58M*$16.98M$21.59M*$282.16M13.67%*$12.82M*$28.87M*$99.00M$15.75M$145.01M-$2.83M
2017-03-31Reported$29.68M(m)(m)(m)11.47%$9.19M$28.88M(m)$15.49M$142.50M-$1.65M
2016-12-31Reported$59.08M(m)(m)(m)23.11%(m)(m)(m)(m)(m)(m)
2016-09-30Reported$48.18M*$30.09M$18.09M*(m)(m)$6.97M*$46.77M*(m)$15.12M$112.32M$4.85M
2016-06-30Reported$40.39M*$22.38M$18.01M*(m)(m)$8.27M*$38.08M*(m)$14.68M$119.22M$2.19M
2016-03-31Reported$40.35M(m)(m)(m)17.04%$10.89M$25.03M(m)$14.45M$111.97M$1.58M
2015-12-31Reported$42.28M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Reported$26.23M*$9.99M$16.23M*(m)(m)$5.36M*$19.61M*(m)$13.94M$113.42M$37.24M
2015-06-30Reported$36.91M*$24.34M$12.56M*(m)(m)$9.62M*$27.98M*(m)$12.01M$99.32M$5.99M
2015-03-31Reported$33.04M(m)(m)(m)16.31%$5.33M$31.62M(m)$11.08M$93.27M$6.06M
2014-12-31Reported$41.97M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30Reported$21.98M*$17.11M$4.88M*(m)(m)$6.42M*$31.07M*(m)$11.13M$93.79M$1.97M
2014-06-30Reported$27.59M*$12.39M$15.20M*(m)(m)$9.36M*$16.38M*(m)$13.74M$115.25M$2.36M
2014-03-31Reported$22.7M(m)(m)(m)10.55%$11.34M$11.25M(m)$12.57M$108.34M$1.77M
2013-12-31Reported$58.47M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30Reported-$19.47M*-$31.14M$11.67M*(m)(m)$13.25M*$30.81M*(m)$13.05M$99.79M-$6.35M
2013-06-30Reported$18.19M*$5.56M$12.64M*(m)(m)$13.62M*$2.92M*(m)$11.81M$103.28M-$947.00K
2013-03-31Reported$9.2M(m)(m)(m)4.68%$10.85M$7.85M(m)$12.72M$102.96M-$1.87M
2012-12-31Reported$32.05M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2012-09-30Reported$33.05M*$19.74M$13.31M*(m)(m)$19.72M*$27.91M*(m)$13.11M$93.08M$1.04M
2012-06-30Reported$31.25M*$18.02M$13.23M*(m)(m)$14.23M*$2.28M*(m)$13.13M$96.10M$3.06M
2012-03-31Reported$30.04M(m)(m)(m)(m)$10.41M$32.32M(m)$11.91M$87.41M$2.90M
2011-12-31Reported$20.62M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2011-09-30Reported$31.14M*$18.29M$12.85M*(m)(m)$12.24M*$23.80M*(m)$13.19M$87.51M$44.00K
2011-06-30Reported$22.49M*$8.00M$14.49M*(m)(m)$7.22M*$24.58M*(m)$12.71M$95.73M$1.30M
2011-03-31Reported$30.83M(m)(m)(m)(m)$5.92M$21.25M(m)$12.15M$80.08M$3.35M
2010-12-31Reported$34.67M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2010-09-30Reported$37.02M*$27.31M$9.71M*(m)(m)$7.21M*$29.65M*(m)$11.72M$75.74M$5.79M
2010-06-30Reported$34.10M*$24.58M$9.52M*(m)(m)$17.64M*$19.36M*(m)$11.76M$74.22M$5.94M
2010-03-31Reported$32.07M(m)(m)(m)(m)-$5.94M$28.14M(m)$11.30M$72.51M$4.09M
2009-12-31Reported$40.42M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-09-30Reported$33.79M*$23.82M$9.97M*(m)(m)$5.68M*$28.37M*(m)$11.53M$69.92M$3.71M
2009-06-30Reported(m)$23.91M(m)(m)(m)(m)(m)(m)$10.30M$68.25M$6.16M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$493.37M(m)$1.64B(m)$81.44M$50.38M$803.63M(m)$699.70M-$47.03M
2024-12-31Reported(m)$28.41M(m)$1.61B(m)$104.42M$129.38M$728.47M(m)$716.98M-$11.29M
2023-12-31Reported(m)$111.53M(m)$1.54B(m)$66.86M$139.96M$656.84M(m)$656.64M$13.33M
2022-12-31Reported(m)$238.92M(m)$1.56B(m)$42.34M$264.47M$587.36M(m)$616.32M$33.34M
2021-12-31Reported(m)$197.23M(m)$1.54B(m)$48.02M$312.43M$597.81M(m)$637.45M$45.60M
2020-12-31Reported(m)$151.37M(m)$1.37B(m)$38.89M$203.83M$520.83M(m)$594.53M-$40.37M
2019-12-31Reported$203.22M(m)(m)(m)13.39%$69.54M$231.43M$564.68M(m)$687.60M$9.90M
2018-12-31Reported$221.73M(m)(m)(m)15.06%$77.74M$199.68M$571.50M$78.04M$690.75M-$3.40M
2017-12-31Reported$133.75M(m)(m)(m)11.26%$43.50M$114.54M$435.51M$63.45M$624.10M-$53.36M
2016-12-31Reported$188.01M(m)(m)(m)18.95%$47.33M$116.41M$349.09M$58.16M$455.63M$15.84M
2015-12-31Reported$138.45M(m)(m)(m)(m)$33.41M$104.85M(m)$50.90M$415.76M$53.82M
2014-12-31Reported$114.29M(m)(m)(m)(m)$38.34M$83.56M(m)$43.56M$375.55M$9.27M
2013-12-31Reported$66.39M(m)(m)(m)(m)$42.30M$53.27M(m)$42.62M$332.19M-$3.24M
2012-12-31Reported$126.39M(m)(m)(m)(m)$69.03M$59.10M(m)$51.01M$373.11M$10.82M
2011-12-31Reported$105.08M(m)(m)(m)(m)$38.42M$104.33M(m)$51.45M$358.13M$505.00K
2010-12-31Reported$137.87M(m)(m)(m)(m)$37.14M$105.57M(m)$48.11M$305.06M$16.45M
2009-12-31Reported$137.51M(m)(m)(m)(m)$25.24M$143.24M(m)$44.28M$281.10M$22.20M
2008-12-31Reported$78.13M(m)(m)(m)(m)$13.40M$72.59M(m)$60.49M$281.00M-$9.19M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92